1. Home
  2. APOG vs ORIC Comparison

APOG vs ORIC Comparison

Compare APOG & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APOG

Apogee Enterprises Inc.

HOLD

Current Price

$35.26

Market Cap

697.8M

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.61

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APOG
ORIC
Founded
1949
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.8M
837.3M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
APOG
ORIC
Price
$35.26
$8.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
13
Target Price
$47.00
$19.73
AVG Volume (30 Days)
172.3K
1.2M
Earning Date
04-24-2026
05-05-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
19.67
EPS
2.52
N/A
Revenue
$1,404,733,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.07
N/A
P/E Ratio
$13.99
N/A
Revenue Growth
3.21
N/A
52 Week Low
$30.75
$4.65
52 Week High
$46.14
$14.93

Technical Indicators

Market Signals
Indicator
APOG
ORIC
Relative Strength Index (RSI) 46.47 34.85
Support Level $33.75 $7.90
Resistance Level $35.88 $11.22
Average True Range (ATR) 1.31 0.50
MACD -0.13 -0.08
Stochastic Oscillator 12.59 5.74

Price Performance

Historical Comparison
APOG
ORIC

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: